METTL3 and nonpapillary renal cell carcinoma: The results showed that ccRCC patients with high METTL14 expression had favorable prognosis (Figure 4D), while ccRCC patients with high METTL3 expression had bad prognosis (Figure 4E), which was in accordance with the LASSSO results and this partly strength the reliability of our findings.